SEC Form 4 research
| Issuer | Tenaya Therapeutics, Inc. |
|---|---|
| Tickers | TNYA |
| Reporting owners | 30 |
| Officers and directors | 9 |
| Last public filing | 2026-09-12 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-11 | 2026-09-10 | Ali Faraz | A | 122,000 | $0 | Not reported |
| 2026-09-11 | 2026-09-10 | Ali Faraz | A | 732,500 | $0 | Not reported |
| 2026-09-11 | 2026-09-10 | Tingley Whittemore | A | 49,000 | $0 | Not reported |
| 2026-09-11 | 2026-09-10 | Tingley Whittemore | A | 293,000 | $0 | Not reported |
| 2026-08-17 | 2026-08-17 | Ali Faraz | S | 7,406 | $0.71 | Not reported |
| 2026-08-17 | 2026-08-17 | Ali Faraz | S | 5,020 | $0.71 | Not reported |
| 2026-08-17 | 2026-08-17 | Ali Faraz | S | 3,969 | $0.71 | Not reported |
| 2026-08-17 | 2026-08-17 | Ali Faraz | S | 5,837 | $0.71 | Not reported |
| 2026-08-17 | 2026-08-17 | Tingley Whittemore | S | 2,279 | $0.71 | Not reported |
| 2026-08-17 | 2026-08-17 | Tingley Whittemore | S | 1,871 | $0.71 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.